This site is intended for healthcare professionals only
LoginRegister
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB PatientsMSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Tablets 10 mg
Indias pharma exports expected to cross USD 30 billion by this year end: Dr Jitendra SinghIndia's pharma exports expected to cross USD 30 billion by this year end: Dr Jitendra Singh
Only Registered Pharmacists Can Be Registrar: Rajasthan Councils New RuleMeghalaya Pharmacists Await Service Rules Even After 50 Years of Statehood
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB PatientsSEC Recommends Phase III Trial of MSN Labs' Vibegron Against Mirabegron in Overactive Bladder
Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan ConcernsHealth crisis in a bottle: Rajasthan govt bans cough syrup batch after patients fall ill in...
Khadgawan CHC Honoured with ISO Certification for Vaccine Storage StandardsNot All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections
Bihar: 56 MBBS Students at DMCH Booked for Protesting Ban on Classes, Hospital StayFake docs, real jobs: Pharmacist at Community Health Centre in Ballia booked in recruitment scam
Wockhardt posts profit of Rs 82 crore in Q2Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative...
Biocon expects 50 percent drop in costs for developing complex biosimilars: Top executiveBiocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US
Alembic Pharma gets USFDA nod for angina drug Diltiazem HydrochlorideLupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric...
Bombay High Court Blocks Use of Deceptively Similar Diabetes Drug TrademarkBombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms
Indian Immunologicals Launches Raksha-IBR, Indias First DIVA Vaccine Against IBRIndian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR
X